Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in pharmacogenomic research and development.

Jeanette J McCarthy1

  • 1San Diego State University, 5500 Campanile Dr., San Diego, CA 92182-4162, USA.

Molecular Biotechnology
|December 12, 2003
PubMed
Summary

Recent advances in pharmacogenomics, driven by human genome sequencing and population studies, are improving our understanding of genetic influences on drug response. This field is rapidly evolving with new technologies and data banks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A note from the editors.

Personalized medicine·2018
Same author

Toward clinical genomics in everyday medicine: perspectives and recommendations.

Expert review of molecular diagnostics·2016
Same author

Clinical application of pharmacogenetics: focusing on practical issues.

Pharmacogenomics·2015
Same author

Driving personalized medicine forward: the who, what, when, and how of educating the health-care workforce.

Molecular genetics & genomic medicine·2015
Same author

Genomic medicine: a decade of successes, challenges, and opportunities.

Science translational medicine·2013
Same author

Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.

Human genetics·2012

Area of Science:

  • Genomics
  • Pharmacology
  • Biotechnology

Background:

  • Recent technological advancements in human genome sequencing have revitalized interest in the genetic basis of drug response.
  • The field of pharmacogenetics/pharmacogenomics is experiencing rapid growth, supported by empirical human genome studies and genetic epidemiology.
  • Understanding individual genetic variations is crucial for predicting drug efficacy and adverse reactions.

Purpose of the Study:

  • To review recent progress in pharmacogenomic research and development.
  • To highlight key areas including human genome architecture, population DNA/data banks, genetic marker validity, and regulatory considerations.

Main Methods:

  • Review of recent scientific literature and technological developments in pharmacogenomics.
  • Analysis of empirical studies on the human genome and genetic epidemiology in patient populations.
  • Examination of advancements in DNA sequencing, polymorphism discovery, and data bank creation.

Main Results:

  • Significant progress has been made in understanding human genome architecture and its relation to drug response.
  • Development of population deoxyribonucleic acid (DNA)/data banks facilitates large-scale genetic research.
  • Assessment of clinical validity for genetic markers is crucial for translating research into practice.
  • Regulatory bodies are increasingly addressing pharmacogenomic data and applications.

Conclusions:

  • Pharmacogenomics is a rapidly advancing field with the potential to personalize drug therapy.
  • Continued research and development in genome sequencing, data management, and clinical validation are essential.
  • Addressing regulatory aspects is key to the successful implementation of pharmacogenomics in healthcare.

Related Experiment Videos